The relationship between serum cystatin C levels and Hughes motor scale in Guillain-Barré syndrome

References

1. 1.↵
   2. Amin F ,
   3. Khan MS ,
   4. Bano B.

   Mammalian cystatin and protagonists in brain diseases. J Biomol Struct Dyn 2019: 1–26.
2. 2.↵
   2. Yang Y ,
   3. Liu S ,
   4. Qin Z ,
   5. Cui Y ,
   6. Qin Y ,
   7. Bai S.

   Alteration of cystatin C levels in cerebrospinal fluid of patients with Guillain-Barre Syndrome by a proteomical approach. Mol Biol Rep 2009; 36: 677–682.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   2. Li P ,
   3. Wang S ,
   4. Zhang R ,
   5. Pei J ,
   6. Chen L ,
   7. Cao Y , et al.

   Identification of CSF biomarkers by proteomics in Guillain-Barre syndrome. Exp Ther Med 2018; 15: 5177–5182.

   OpenUrl
4. 4.↵
   Association NboNboCM. Chinese Guillain Barre syndrome diagnosis and treatment guidelines. Chinese Journal of Neurology 2019; 52: 877–882.

   OpenUrl
5. 5.↵
   2. Hughes RAC ,
   3. Newsom-Davis JM ,
   4. Perkin GD ,
   5. Pierce JM.

   Controlled trial of prednisolone in acute polyneuropathy. Lancet 1978; 312: 750–753.

   OpenUrlCrossRef
6. 6.↵
   2. Hoorn EJ ,
   3. Zietse R.

   Diagnosis and Treatment of Hyponatremia: Compilation of the Guidelines. Journal of the American Society of Nephrology. JASN 2017; 28: 1340–1349.

   OpenUrl
7. 7.↵
   2. Hadden RD ,
   3. Cornblath DR ,
   4. Hughes RA ,
   5. Zielasek J ,
   6. Hartung HP ,
   7. Toyka KV , et al.

   Electrophysiological classification of Guillain-Barre syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome Trial Group. Ann Neurol 1998; 44: 780–788.

   OpenUrlCrossRefPubMedWeb of Science
8. 8.↵
   2. Esposito S ,
   3. Longo MR.

   Guillain-Barre syndrome. Autoimmun Rev 2017; 16: 96–101.

   OpenUrl
9. 9.↵
   2. Wang Y ,
   3. Shang P ,
   4. Xin M ,
   5. Bai J ,
   6. Zhou C ,
   7. Zhang HL.

   The usefulness of chief complaints to predict severity, ventilator dependence, treatment option, and short-term outcome of patients with Guillain-Barré syndrome: a retrospective study. BMC Neurol 2017; 17: 200.

   OpenUrl
10. 10.↵
    2. Alanazy MH ,
    3. Bakry SS ,
    4. Alqahtani A ,
    5. AlAkeel NS ,
    6. Alazwary N ,
    7. Osman AM , et al.

    Clinical features and outcome of Guillain-Barre syndrome in Saudi Arabia: a multicenter, retrospective study. BMC neurology 2021; 21: 275.

    OpenUrl
11. 11.↵
    2. Shang P ,
    3. Zhu M ,
    4. Wang Y ,
    5. Zheng X ,
    6. Wu X ,
    7. Zhu J , et al.

    Axonal variants of Guillain-Barré syndrome: an update. J Neurol 2021; 268: 2402–2419.

    OpenUrl
12. 12.↵
    2. Gupta PK ,
    3. Singhi P ,
    4. Singhi S ,
    5. Kasinathan A ,
    6. Sankhyan N.

    How Different is AMAN from AIDP in Childhood GBS? A Prospective Study from North India. Indian J Pediatr 2019; 86: 329–334.

    OpenUrl
13. 13.↵
    2. Tian J ,
    3. Cao C ,
    4. Li T ,
    5. Zhang K ,
    6. Li P ,
    7. Liu Y , et al.

    Electrophysiological Subtypes and Prognostic Factors of Guillain-Barre Syndrome in Northern China. Front Neurol 2019; 10: 714.

    OpenUrl
14. 14.↵
    2. Rumalla K ,
    3. Reddy AY ,
    4. Letchuman V ,
    5. Mittal MK.

    Hyponatremia in Guillain-Barré Syndrome. J Clin Neuromuscul Dis 2017; 18: 207–217.

    OpenUrl
15. 15.↵
    2. Sipilä JO ,
    3. Kauko T ,
    4. Soilu-Hänninen M.

    Admission sodium level and prognosis in adult Guillain-Barré syndrome. Int J Neurosci 2017; 127: 344–349.

    OpenUrl
16. 16.↵
    2. Illes Z ,
    3. Blaabjerg M.

    Cerebrospinal fluid findings in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathies. Handb Clin Neurol 2017; 146: 125–138.

    OpenUrlPubMed
17. 17.↵
    2. Yan P ,
    3. Zhang Z ,
    4. Xu Y ,
    5. Wan Q ,
    6. Ma H ,
    7. He J.

    [Relationship between serum cystatin-C levels and vibrating perception threshold in patients with Type 2 diabetes mellitus]. Journal of Central South University Medical sciences 2016; 41: 58–64. Chinese

    OpenUrl
18. 18.↵
    2. Constant O ,
    3. Barthelemy J ,
    4. Bolloré K ,
    5. Tuaillon E ,
    6. Gosselet F ,
    7. Chable-Bessia C , et al.

    SARS-CoV-2 Poorly Replicates in Cells of the Human Blood-Brain Barrier Without Associated Deleterious Effects. Front Immunol 2021; 12: 697329.

    OpenUrl
19. 19.↵
    2. Shang P ,
    3. Feng J ,
    4. Wu W ,
    5. Zhang HL.

    Intensive Care and Treatment of Severe Guillain-Barré Syndrome. Front. Pharmacol 2021; 12: 608130.

    OpenUrl
20. 20.↵
    2. Hou S ,
    3. Kumar A ,
    4. Xu Z ,
    5. Airo AM ,
    6. Stryapunina I ,
    7. Wong CP , et al.

    Zika Virus Hijacks Stress Granule Proteins and Modulates the Host Stress Response. J Virol 2017; 91: e00474–17.

    OpenUrl
21. 21.↵
    2. Yuan Y ,
    3. Wu W ,
    4. Chen M ,
    5. Cai F ,
    6. Fan C ,
    7. Shen W , et al.

    Reward Inhibits Paraventricular CRH Neurons to Relieve Stress. Curr Biol 2019; 29: 1243–1251.e4.

    OpenUrlCrossRef
22. 22.↵
    2. Rodríguez Y ,
    3. Rojas M ,
    4. Pacheco Y ,
    5. Acosta-Ampudia Y ,
    6. Ramírez-Santana C ,
    7. Monsalve DM , et al.

    Guillain-Barré syndrome, transverse myelitis and infectious diseases. Cell Mol Immunol 2018; 15: 547–562.

    OpenUrl